Beyond Air (NASDAQ:XAIR) Earns Buy Rating from D. Boral Capital

Beyond Air (NASDAQ:XAIR)‘s stock had its “buy” rating restated by research analysts at D. Boral Capital in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $11.00 target price on the stock.

Several other analysts have also recently issued reports on the stock. Weiss Ratings reaffirmed a “sell (e)” rating on shares of Beyond Air in a research note on Monday, December 22nd. Rodman & Renshaw initiated coverage on Beyond Air in a report on Tuesday. They issued a “buy” rating for the company. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $11.00.

Beyond Air Stock Performance

Shares of NASDAQ:XAIR opened at $1.77 on Wednesday. The company has a debt-to-equity ratio of 0.77, a current ratio of 4.24 and a quick ratio of 3.73. Beyond Air has a 1 year low of $0.67 and a 1 year high of $10.40. The firm has a market capitalization of $14.18 million, a PE ratio of -0.23 and a beta of 0.34. The business’s 50 day moving average price is $1.17 and its 200-day moving average price is $2.06.

Beyond Air (NASDAQ:XAIR) last announced its quarterly earnings data on Monday, November 10th. The company reported ($1.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.10) by ($0.15). Beyond Air had a negative net margin of 632.51% and a negative return on equity of 261.08%. The firm had revenue of $1.82 million during the quarter, compared to analysts’ expectations of $2.54 million. As a group, equities research analysts expect that Beyond Air will post -0.79 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Alpine Global Management LLC purchased a new stake in shares of Beyond Air in the 3rd quarter valued at approximately $25,000. Osaic Holdings Inc. increased its holdings in Beyond Air by 26.4% in the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock valued at $29,000 after purchasing an additional 34,000 shares during the last quarter. Virtu Financial LLC acquired a new stake in Beyond Air in the 3rd quarter valued at approximately $48,000. Wealth Effects LLC raised its position in Beyond Air by 42.5% in the second quarter. Wealth Effects LLC now owns 278,100 shares of the company’s stock valued at $48,000 after purchasing an additional 83,000 shares during the period. Finally, Geode Capital Management LLC lifted its stake in Beyond Air by 1.5% during the second quarter. Geode Capital Management LLC now owns 838,319 shares of the company’s stock worth $144,000 after purchasing an additional 12,598 shares in the last quarter. Hedge funds and other institutional investors own 31.50% of the company’s stock.

Beyond Air Company Profile

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.